BCRX: BioCryst Pharmaceuticals Inc

8.88 USD 0.08 (0.89%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de BCRX de hoy ha cambiado un -0.89%. En este caso, el precio mínimo en el mercado ha alcanzado 8.85, mientras que el máximo ha alcanzado 9.07.

Siga la dinámica de la pareja de divisas BioCryst Pharmaceuticals Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

BCRX News

Investing 11:05 BioCryst Pharmaceuticals appoints Babar Ghias as CFO
Benzinga 14:41 BioCryst Just Ditched Its Europe Business — Here's Why Investors Are Cheering - BioCryst Pharma (NASDAQ:BCRX)
Investing 12:19 BioCryst stock rises after $264 million sale of European ORLADEYO business
Investing 11:04 BioCryst to sell European ORLADEYO business to Neopharmed for $264M
Investing 11:04 FDA extends review period for BioCryst pediatric drug application to December
Investing 11:09 BioCryst reports long-term efficacy of ORLADEYO in HAE treatment
Investing 11:06 Colombia approves BioCryst’s oral HAE treatment ORLADEYO
Investing 14:15 BioCryst at Goldman Sachs Conference: Strategic Growth and Profitability
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Investing 11:05 Netherlands approves BioCryst’s HAE drug ORLADEYO for reimbursement
Investing 11:36 biocryst pharmaceuticals extends cfo consulting agreement
Investing 11:32 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:32 BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
Investing 11:06 BioCryst reports efficacy of HAE drug across age groups
Investing 13:44 Cantor Fitzgerald maintains overweight on Metsera shares
Investing 11:28 BioCryst to Present at Upcoming Investor Conferences
Investing 11:05 BioCryst reports ORLADEYO reduces severe HAE attack rates
Benzinga 21:29 BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors - BioCryst Pharma (NASDAQ:BCRX)
Benzinga 14:16 Napco Security Technologies Posts Better-Than-Expected Results, Joins Skechers, BioCryst Pharmaceuticals And Other Big Stocks Moving Higher On Monday - American Axle & Mfg Hldgs (NYSE:AXL), BioCryst Pharma (NASDAQ:BCRX)
Seeking Alpha 12:45 BioCryst: Hold Steady As Orladeyo Builds, But Competition Heats Up (NASDAQ:BCRX)
Seeking Alpha 23:24 BioCryst: Upgrade To Hold On Strong 2024 Orladeyo Sales, But I Remain Skeptical
The Motley Fool 23:15 Why BioCryst Pharmaceuticals Stock Tumbled by 10% Today
The Motley Fool 21:30 BioCryst Pharmaceuticals (BCRX) Q4 2024 Earnings Call Transcript
Seeking Alpha 17:17 BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2024 Earnings Call Transcript

Rango diario

8.85 9.07

Rango anual

6.01 11.31

Cierres anteriores: 9.06
Open: 8.96

Bid: 8.88
Ask: 9.18

Low: 8.85
High: 9.07

Volumen: 4.695 K

Cambio diario: -0.89%
Cambio mensual: -1.11%

Cambio a 6 meses: 15.03%
Cambio anual: 21.64%

11 julio, viernes